Urgent.News

What's breaking now, across thousands of outlets.

Science

CRISPR and the future we are editing

CRISPR has given rise to a booming biotechnology sector, with startups, pharmaceutical giants, and agricultural corporations investing billions.

CRISPR and the future we are editing

CRISPR/Cas9 genome engineering has revolutionized biological research and gene therapy development, but it is limited by the positioning and quality of guide RNAs relative to the desired edit site. The SMART technique overcomes this constraint by subtly altering the gap between the Cas9 cut site and the edit in the repair template, preserving protein function while expanding design possibilities.

However, creating these templates manually requires complex coordination of multiple factors. Auto-SMART is a web-based platform that streamlines this process for CRISPR/Cas9-mediated insertions, deletions, point mutations, and sequence replacements in both coding exons and introns. Users specify the genome assembly, search for a gene or transcript, select a modification site, and choose an editing operation.

The platform identifies nearby Streptococcus pyogenes Cas9 (SpCas9) guides, ranks them by predicted on-target activity and cut-to-edit geometry, constructs repair templates with synonymous substitutions, automatically avoids re-cutting on residual on-target sites, and generates interpretable visual panels. These include the target locus, repair template, locus after HDR, and a downloadable report with a Primer3 genotyping handoff. The Auto-SMART web application is freely accessible at https://auto-smart.chuanping.org/.

Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at hindustantimes.com →

More in Science

In This Issue

Proceedings of the National Academy of Sciences, Volume 123, Issue 38, September 2026.

More from Tuesday 22 September →